Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-58
Closed -$6.02K 601
2026
Q1
$6.02K Hold
58
﹤0.01% 418
2025
Q4
$5.8K Buy
58
+1
+2% +$109 ﹤0.01% 413
2025
Q3
$7.02K Buy
57
+1
+2% +$124 ﹤0.01% 386
2025
Q2
$6.76K Hold
56
﹤0.01% 362
2025
Q1
$8.22K Buy
56
+1
+2% +$153 ﹤0.01% 307
2024
Q4
$8.99K Hold
55
﹤0.01% 301
2024
Q3
$8.96K Hold
55
0.01% 297
2024
Q2
$7.44K Buy
55
+1
+2% +$139 ﹤0.01% 299
2024
Q1
$8.28K Hold
54
0.01% 301
2023
Q4
$7.65K Buy
54
+1
+2% +$133 0.01% 296
2023
Q3
$6.97K Hold
53
0.01% 285
2023
Q2
$8.39K Buy
53
+1
+2% +$161 0.01% 279
2023
Q1
$8.29K Hold
52
0.01% 231
2022
Q4
$7.3K Buy
+52
New +$7.38K 0.01% 236

Other funds holding CLX

PFS Partners's CLX Position: Q2 2026 in Review

PFS Partners sold out of Clorox (CLX) in Q2 2026, closing a stake of 58 shares — an estimated $6.02K sold.

PFS Partners first reported a position in CLX in Q4 2022 and held it in 14 quarters. The position peaked at $8.99K in Q4 2024. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • PFS Partners reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • PFS Partners sold 58 Clorox shares in Q2 2026, an estimated $6.02K.
  • PFS Partners first reported a position in Clorox in Q4 2022 and held it in 14 quarters.
  • PFS Partners's Clorox position peaked at $8.99K in Q4 2024.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.